December 9, 2022
Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium.
KKR acquired Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4 billion fund focused on investing in high-growth healthcare companies. Financial details of the transaction were not disclosed.
The Gibson Dunn team also included advice provided by Technology Transactions Partners Alison Beal and Joel Harrison, Employment Partner James Cox, Real Estate Co-Chair Alan Samson, Tax Co-Chair Sandy Bhogal, Dispute Resolution Partner Patrick Doris, Antitrust and Competition Partners Ali Nikpay and Attila Borsos, and Global Finance Partner Ben Myers.
The Firm also advised KKR, amongst other matters, on its minority investment in Norwegian telecommunications company Telenor in October and on its Series C investment in Privy, a leading digital trust provider in Indonesia, in November.